AstraZeneca partners with Oxford University to produce Covid-19 vaccine
https://www.theguardian.com/society/2020/apr/30/astrazeneca-partners-with-oxford-university-to-produce-covid-19-vaccine
AstraZeneca partners with Oxford University to produce Covid-19 vaccine
Joanna Partridge
Published on Thu 30 Apr 2020 17.50 BST
AstraZeneca, the Cambridge-based pharmaceutical group, is teaming up with Oxford University to manufacture and distribute a coronavirus vaccine if clinical trials currently under way show it is effective.
News of the partnership boosted AstraZenecas share price, helping it to become Britains most valuable company by market capitalisation.
The potential vaccine, aimed at preventing Covid-19 infection, is being developed at Oxford and is being tested on more than 1,100 healthy human volunteers in the first phase of clinical trials at five centres in southern England.
(snip)
More than 1,000 volunteers aged between 18 and 55 are taking part in trials of the vaccine, called ChAdOx1 nCoV-19, at five test centres. The results of the trials could be available from May.
If the vaccine proves successful, late-stage trials could take place in the middle of this year, in a significant acceleration of the usual vaccine testing process.
(snip)